.jpg)
15 hours ago
3
Article content
Personalised treatment plans pair medication with unlimited Care Team support, nutrition and lifestyle guidance, and Canadian medical expertise, starting at $149/month
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
TORONTO — Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the availability of generic semaglutide through its platform for eligible customers in Canada. This makes affordable GLP-1 treatment accessible to Canadians for whom cost has long been a barrier to treatment. For eligible customers, personalised treatment plans are available starting at $149/month CAD.
Article content
Article content
Article content
GLP-1 treatments have transformed obesity and metabolic health, with their significance extending well beyond weight alone. Nearly two-thirds of Canadian adults are overweight or living with obesity, but cost has remained a significant barrier to access the treatment they need. Health Canada’s authorization of generic semaglutide marks a turning point, not just for Hims & Hers customers, but for the country’s broader healthcare landscape. This will help create a more dynamic GLP-1 market. As more providers offer access to affordable options, prices fall across the board, expanding access for patients regardless of where they seek care.
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
Through Hims & Hers, eligible customers in Canada will have access to personalised care plans that may include GLP-1 options, alongside unlimited and ongoing Care Team access and evidence-informed resources built around nutrition, movement, and sleep, all designed to support sustainable, lasting health habits. All Canadian customers are connected with Canadian providers who understand the healthcare landscape they’re navigating and bring the local expertise and clinical rigour this kind of care demands.
Article content
“Generics have always played a critical role in expanding access to medicines that change lives,” said Dr. Sandy Van, Obesity Medicine Specialist and Chief Medical Officer, Hims & Hers Canada. “Today marks a turning point: more choice, lower costs, and a genuine commitment to care built around the whole patient. Every Canadian deserves access to the treatment that’s right for them, regardless of what they can afford.”
Article content
“Canada has a strong health system, and we are committed to helping support and strengthen it,” said Austin Kouri, General Manager, Hims & Hers Canada. “Bringing generic semaglutide to market means more Canadians have a real, affordable path to treatment. When patients have options and costs come down, everyone benefits. That’s exactly the kind of impact we’re here to create.”
Article content
Hims & Hers is committed to putting the right tools, the right providers, and the right support into the hands of Canadians who are ready to take control of their health.
Article content
Generic semaglutide is authorized for sale by Health Canada for the management of Type 2 diabetes. It may be prescribed off-label for weight management in a licensed healthcare provider’s sole clinical judgment. Hims & Hers Canada Inc. does not currently offer access to treatment services for Type 2 diabetes.
Article content
Article content
About Hims & Hers Health, Inc.
Article content
Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the company provides access to personalized care designed for results. For more information, please visit www.hims.ca and www.forhers.ca.
Article content
Article content
Article content
Article content
View source version on businesswire.com:
Article content
Article content
Article content
Contacts
Article content
Press Contact
Article content
Article content
Susan Cadrecha
Article content
Article content
Article content
English (US)